According to the BeiGene announcement, the 2026 business performance forecast has been adjusted, and the estimated revenue will be raised from 436-45.2 billion yuan to 449-46.2 billion yuan, gross margin will remain high in the 80% range, and there will be no change in total R&D expenses. Revenue deducting operating expenses was raised from RMB 4.8-5.5 billion to RMB 65-7.1 billion, and adjusted operating expenses were raised from RMB 10-10.6 billion to RMB 115-12.2 billion. The adjustment was due to the expansion of Baiyuze in markets such as the US. Performance forecasts are uncertain, and investors are reminded to be aware of risks.

According to the BeiGene announcement, the 2026 business performance forecast has been adjusted, and the estimated revenue will be raised from 436-45.2 billion yuan to 449-46.2 billion yuan, gross margin will remain high in the 80% range, and there will be no change in total R&D expenses. Revenue deducting operating expenses was raised from RMB 4.8-5.5 billion to RMB 65-7.1 billion, and adjusted operating expenses were raised from RMB 10-10.6 billion to RMB 115-12.2 billion. The adjustment was due to the expansion of Baiyuze in markets such as the US. Performance forecasts are uncertain, and investors are reminded to be aware of risks.